1,083 results on '"Baltzer, Pascal A"'
Search Results
2. Image quality of DWI at breast MRI depends on the amount of fibroglandular tissue: implications for unenhanced screening
3. Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis: A Systematic Review and Meta-Analysis.
4. A survey by the European Society of Breast Imaging on radiologists’ preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography
5. A model combining BI-RADS® descriptors from pre-treatment B-mode breast ultrasound with clinicopathological tumor features shows promise in the prediction of residual disease after neoadjuvant chemotherapy
6. Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database
7. Evaluation of apparent diffusion coefficient (ADC) with regards to reproducibility and diagnostic accuracy as well as possible significance of pre - and post - contrast acquisition and employment of different b values
8. Pilot study: A simple CAD-based tool to detect breast cancer on MRI of the breast
9. European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision
10. Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer"
11. Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
12. Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis.
13. Reliability of signal intensity in the basal ganglia on non-contrast T1-weighted MR scans after repetitive application of a gadolinium-based contrast agent in pediatric neuro-oncology patients
14. Added value of clinical decision rules for the management of enhancing breast MRI lesions: A systematic comparison of the Kaiser score and the Göttingen score
15. Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI
16. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer
17. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI
18. Multiparametric 18F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?
19. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
20. Breast MRI: does a clinical decision algorithm outweigh reader experience?
21. A survey by the European Society of Breast Imaging on the implementation of breast diffusion-weighted imaging in clinical practice
22. Overview of Breast DWI: Diagnosis of Suspicious Lesions Using DWI in Combination With Standard MRI
23. List of Contributors
24. Diffusion Tensor Imaging (DTI) of the Breast
25. Imaging of Ductal Carcinoma In Situ (DCIS)
26. Performance of Diffusion-weighted Imaging–based Noncontrast MRI Protocols for Diagnosis of Breast Cancer: A Systematic Review and Meta-Analysis
27. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
28. Automated detection and segmentation of non-mass enhancing breast tumors with dynamic contrast-enhanced magnetic resonance imaging
29. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
30. A multiparametric [18F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis.
31. Correction to: Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
32. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
33. Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment.
34. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
35. Feasibility and Optimal Time Point of [68Ga]Gallium-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography Imaging in Patients Undergoing Cytoreductive Surgery After Systemic Therapy for Primary Oligometastatic Prostate Cancer: Implications for Patient Selection and Extent of Surgery
36. Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis
37. The potential of predictive and prognostic breast MRI (P2-bMRI)
38. Recommendations of the German Radiological Society's breast imaging working group regarding breast MRI.
39. Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET
40. Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
41. One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
42. Contrast Agent Dynamics Determine Radiomics Profiles in Oncologic Imaging
43. Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations
44. 3T MRI signal intensity profiles and thicknesses of transient zones in human fetal brain at mid-gestation
45. Technische Durchführung der MRT bei Rektumkarzinom
46. The Mantra about Low Specificity Specificity of Breast MRI
47. An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
48. Imaging of Ductal Carcinoma In Situ (DCIS)
49. The Kaiser score: an evidence-based clinical decision rule for dynamic contrast-enhanced breast MRI
50. Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.